Skip to main content
Veterinary Medicines

PROGRAM Plus

Not authorised
  • Milbemycin oxime
  • Lufenuron

Product identification

Medicine name:
PROGRAM Plus
Program Plus 11,5 mg/230 mg, überzogene Tablette für Hunde
Active substance:
  • Milbemycin oxime
  • Lufenuron
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Milbemycin oxime
    11.50
    milligram(s)
    /
    1.00
    Tablet
  • Lufenuron
    230.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
Package description:
  • Carton container containing 8 pentagonal tablets in PVDC/PVC blisters, thermosealed with aluminium foil, boxed in a free-opening, labelled carton
  • Carton container containing 6 pentagonal tablets in PVDC/PVC blister, thermosealed with aluminium foil, boxed in a free-opening, labelled carton

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00501
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0106/003

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
German (PDF)
Published on: 25/08/2021
Updated on: 5/05/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/03/2019
Updated on: 5/05/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/01/2020
Updated on: 5/05/2024